Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Oxid Med Cell Longev ; 2016: 5923938, 2016.
Article in English | MEDLINE | ID: mdl-26881032

ABSTRACT

It is well recognized that mitochondrial dysfunction contributes to neurodegeneration occurring in Alzheimer's disease (AD). However, evidences of mitochondrial defects in AD peripheral cells are still inconclusive. Here, some mitochondrial-encoded and nuclear-encoded proteins, involved in maintaining the correct mitochondria machine, were investigated in terms of protein expression and enzymatic activity in peripheral blood mononuclear cells (PBMCs) isolated from AD and Mild Cognitive Impairment (MCI) patients and healthy subjects. In addition mitochondrial DNA copy number was measured by real time PCR. We found some differences and some similarities between AD and MCI patients when compared with healthy subjects. For example, cytochrome C and cytochrome B were decreased in AD, while MCI showed only a statistical reduction of cytochrome C. On the other hand, both AD and MCI blood cells exhibited highly nitrated MnSOD, index of a prooxidant environment inside the mitochondria. TFAM, a regulator of mitochondrial genome replication and transcription, was decreased in both AD and MCI patients' blood cells. Moreover also the mitochondrial DNA amount was reduced in PBMCs from both patient groups. In conclusion these data confirmed peripheral mitochondria impairment in AD and demonstrated that TFAM and mtDNA amount reduction could be two features of early events occurring in AD pathogenesis.


Subject(s)
Alzheimer Disease/blood , Cognitive Dysfunction/blood , Leukocytes, Mononuclear/cytology , Mitochondria/pathology , Aged , Aged, 80 and over , Case-Control Studies , Cell Nucleus/metabolism , Cytochromes b/metabolism , Cytochromes c/metabolism , DNA, Mitochondrial/metabolism , Female , Gene Dosage , Humans , Male , Middle Aged , Mitochondria/metabolism , Oxidants/metabolism , Oxidation-Reduction , Real-Time Polymerase Chain Reaction , Superoxide Dismutase/metabolism
2.
Int J Immunopathol Pharmacol ; 26(3): 633-46, 2013.
Article in English | MEDLINE | ID: mdl-24067460

ABSTRACT

The beneficial effects of hot springs have been known for centuries and treatments with sulphurous thermal waters are recommended in a number of chronic pathologies as well as acute recurrent infections. However, the positive effects of the therapy are often evaluated in terms of subjective sense of wellbeing and symptomatic clinical improvements. Here, the effects of an S-based compound (NaSH) and of a specific sulphurous thermal water characterized by additional ions such as sodium chloride, bromine and iodine (STW) were investigated in terms of cytokine release and anti-oxidant enzyme activity in primary human monocytes and in saliva from 50 airway disease patients subjected to thermal treatments. In vitro, NaSH efficiently blocked the induction of pro-inflammatory cytokines and counterbalanced the formation of ROS. Despite STW not recapitulating these results, possibly due to the low concentration of S-based compounds reached at the minimum non-toxic dilution, we found that it enhanced the release of IL-10, a potent anti-inflammatory cytokine. Notably, higher levels of IL-10 were also observed in patients' saliva following STW treatment and this increase correlated positively with salivary catalase activity (r2 = 0.19, *p less than 0.01). To our knowledge, these results represent the first evidence suggesting that S-based compounds and STW may prove useful in facing chronic inflammatory and age-related illness due to combined anti-inflammatory and anti-oxidant properties.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Balneology , Enzymes/metabolism , Hot Springs , Inflammation/therapy , Interleukin-10/metabolism , Leukocytes, Mononuclear/drug effects , Mineral Waters , Respiratory Tract Diseases/therapy , Adult , Aged , Catalase/metabolism , Cells, Cultured , Female , Glutathione Peroxidase/metabolism , Humans , Inflammation/enzymology , Inflammation/immunology , Inflammation Mediators/metabolism , Italy , Leukocytes, Mononuclear/enzymology , Leukocytes, Mononuclear/immunology , Male , Middle Aged , NADPH Oxidases/metabolism , Reactive Oxygen Species/metabolism , Respiratory Tract Diseases/enzymology , Respiratory Tract Diseases/immunology , Saliva/enzymology , Saliva/immunology , Sulfides/pharmacology , Superoxide Dismutase/metabolism , Time Factors
3.
Cell Death Dis ; 4: e484, 2013 Feb 07.
Article in English | MEDLINE | ID: mdl-23392172

ABSTRACT

The role of p53 in neurodegenerative diseases is essentially associated with neuronal death. Recently an alternative point of view is emerging, as altered p53 conformation and impaired protein function have been found in fibroblasts and blood cells derived from Alzheimer's disease patients. Here, using stable transfected SH-SY5Y cells overexpressing APP751wt (SY5Y-APP) we demonstrated that the expression of an unfolded p53 conformation compromised neuronal functionality. In particular, these cells showed (i) augmented expression of amyloid precursor protein (APP) and its metabolites, including the C-terminal fragments C99 and C83 and ß-amyloid peptide (ii) high levels of oxidative markers, such as 4-hydroxy-2-nonenal Michael-adducts and 3-nitro-tyrosine and (iii) altered p53 conformation, mainly due to nitration of its tyrosine residues. The consequences of high-unfolded p53 expression resulted in loss of p53 pro-apoptotic activity, and reduction of growth-associated protein 43 (GAP-43) mRNA and protein levels. The role of unfolded p53 in cell death resistance and lack of GAP-43 transcription was demonstrated by ZnCl(2) treatment. Zinc supplementation reverted p53 wild-type tertiary structure, increased cells sensitivity to acute cytotoxic injury and GAP-43 levels in SY5Y-APP clone.


Subject(s)
GAP-43 Protein/metabolism , Neurons/metabolism , Tumor Suppressor Protein p53/chemistry , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Chlorides/pharmacology , GAP-43 Protein/genetics , Humans , Hydrogen Peroxide/toxicity , Oxidative Stress , Protein Structure, Tertiary , Protein Unfolding , RNA, Messenger/metabolism , Transcription, Genetic/drug effects , Tumor Suppressor Protein p53/metabolism , Tyrosine/analogs & derivatives , Tyrosine/chemistry , Zinc Compounds/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...